. "Nov\u011Bj\u0161\u00ED poznatky o metabolick\u00E9m syndromu a jeho l\u00E9\u010Db\u011B" . "Metabolick\u00FD syndrom p\u0159edstavuje sou\u010Dasn\u00FD v\u00FDskyt vz\u00E1jemn\u011B souvisej\u00EDc\u00EDch rizikov\u00FDch faktor\u016F vzniku kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED a diabetes mellitus typu 2. Pat\u0159\u00ED sem porucha regulace gluk\u00F3zov\u00E9ho metabolismu, arteri\u00E1ln\u00ED hypertenze a dyslipid\u00E9mie a zejm\u00E9na inzul\u00EDnov\u00E1 rezistence a abdomin\u00E1ln\u00ED obesita. V sou\u010Dasn\u00E9 dob\u011B je k metabolick\u00E9mu syndromu \u0159azena \u0159ada dal\u0161\u00EDch abnormalit a chorobn\u00FDch stav\u016F, jako nap\u0159. chronick\u00FD z\u00E1n\u011Btliv\u00FD, prokoagula\u010Dn\u00ED a protrombotick\u00FD stav, hyperurik\u00E9mie, mikroalbuminurie, m\u00EDrn\u00E1 hyperhomocystein\u00E9mie, oxida\u010Dn\u00ED stres, nealkoholick\u00E1 steatoza jater, syndrom sp\u00E1nkov\u00E9 apnoe a dal\u0161\u00ED. Metabolick\u00FD syndrom je spojen se zv\u00FD\u0161en\u00FDm v\u00FDskytem n\u011Bkter\u00FDch n\u00E1dor\u016F a neurodegenerativn\u00EDch onemocn\u011Bn\u00ED. Etiopatogeneza metabolick\u00E9ho syndromu je multifaktori\u00E1ln\u00ED. Uplat\u0148uj \u00ED se zejm\u00E9na abdomin\u00E1ln\u00ED obezita, fyzick\u00E1 inaktivita, vlivy diety a st\u00E1rnut\u00ED v interakci s vlivy genetick\u00FDmi. V \u010Dl\u00E1nku je pod\u00E1n p\u0159ehled vz\u00E1jemn\u00E9ho ovlivn\u011Bn\u00ED jednotliv\u00FDch patogenetick\u00FDch faktor\u016F a jsou diskutov\u00E1ny mo\u017Enosti preventivn\u00EDch a l\u00E9\u010Debn\u00FDch, nefarmakologick\u00FDch i farmakologick\u00FDch opat\u0159en\u00ED."@cs . "154768" . "RIV/00064165:_____/12:12861!RIV13-MZ0-00064165" . . "\u017D\u00E1k, Ale\u0161" . . "Nov\u011Bj\u0161\u00ED poznatky o metabolick\u00E9m syndromu a jeho l\u00E9\u010Db\u011B" . . . "Newer knowledge on metabolic syndrome and its treatment"@en . "I" . . "2"^^ . "RIV/00064165:_____/12:12861" . "Newer knowledge on metabolic syndrome and its treatment"@en . "Ateroskler\u00F3za" . "1-2" . . . "4"^^ . . "Metabolic syndrome (MS) is characterized as a cluster of risk factors for athero-thrombotic cardiovascular disease and type 2 diabetes mellitus. The main components of MS are intraabdominal adipose tissue distribution, impaired glucose metabolism, atherogenic dyslipidemia (low high-density lipoprotein cholesterol, hypertriglyceridemia), and arterial hypertension. Nowadays, hyperuricaemia, mild hyperhomocysteinaemia, liver steatosis, and sleep apnoe syndrome are linked to MS. In the MS etiology several mechanisms were shown to take part. Among them genetic and environmental factors (low grade of physical activity, dietary factors, and aging) are the most important. Moreover, insulin resistance, chronic low-grade inflammation (both systemic and of adipose tissue), endothelial dysfunction, and oxidative stress play a role in pathogenesis of MS; however, their interactions have not been fully elucidated at present. There are stated preventive and treatment modalities of MS and its individual component."@en . . . "Vecka, Marek" . "Metabolick\u00FD syndrom p\u0159edstavuje sou\u010Dasn\u00FD v\u00FDskyt vz\u00E1jemn\u011B souvisej\u00EDc\u00EDch rizikov\u00FDch faktor\u016F vzniku kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED a diabetes mellitus typu 2. Pat\u0159\u00ED sem porucha regulace gluk\u00F3zov\u00E9ho metabolismu, arteri\u00E1ln\u00ED hypertenze a dyslipid\u00E9mie a zejm\u00E9na inzul\u00EDnov\u00E1 rezistence a abdomin\u00E1ln\u00ED obesita. V sou\u010Dasn\u00E9 dob\u011B je k metabolick\u00E9mu syndromu \u0159azena \u0159ada dal\u0161\u00EDch abnormalit a chorobn\u00FDch stav\u016F, jako nap\u0159. chronick\u00FD z\u00E1n\u011Btliv\u00FD, prokoagula\u010Dn\u00ED a protrombotick\u00FD stav, hyperurik\u00E9mie, mikroalbuminurie, m\u00EDrn\u00E1 hyperhomocystein\u00E9mie, oxida\u010Dn\u00ED stres, nealkoholick\u00E1 steatoza jater, syndrom sp\u00E1nkov\u00E9 apnoe a dal\u0161\u00ED. Metabolick\u00FD syndrom je spojen se zv\u00FD\u0161en\u00FDm v\u00FDskytem n\u011Bkter\u00FDch n\u00E1dor\u016F a neurodegenerativn\u00EDch onemocn\u011Bn\u00ED. Etiopatogeneza metabolick\u00E9ho syndromu je multifaktori\u00E1ln\u00ED. Uplat\u0148uj \u00ED se zejm\u00E9na abdomin\u00E1ln\u00ED obezita, fyzick\u00E1 inaktivita, vlivy diety a st\u00E1rnut\u00ED v interakci s vlivy genetick\u00FDmi. V \u010Dl\u00E1nku je pod\u00E1n p\u0159ehled vz\u00E1jemn\u00E9ho ovlivn\u011Bn\u00ED jednotliv\u00FDch patogenetick\u00FDch faktor\u016F a jsou diskutov\u00E1ny mo\u017Enosti preventivn\u00EDch a l\u00E9\u010Debn\u00FDch, nefarmakologick\u00FDch i farmakologick\u00FDch opat\u0159en\u00ED." . . "12"^^ . "Nov\u011Bj\u0161\u00ED poznatky o metabolick\u00E9m syndromu a jeho l\u00E9\u010Db\u011B"@cs . "16" . . . "Zeman, Miroslav" . . "1335-2253" . "SK - Slovensk\u00E1 republika" . . . "[4E5AA63FFAA1]" . . "Nov\u011Bj\u0161\u00ED poznatky o metabolick\u00E9m syndromu a jeho l\u00E9\u010Db\u011B"@cs . "Metabolic syndrome; atherosclerosis; cholesterol; cardiovascular disease; diabetes mellitus"@en . "Tvrzick\u00E1, Eva" .